Inventor · disambiguated record
Xiao Luo
Also filed as: LUO XIAO · Luo Xiao Guang
5 granted patents·5 pending applications·8 citations·filing 2016–2022
70Inventor score
Files withENZYMASTER NINGBO BIO ENG CO LTD2IBM2JIANGSU HENGRUI MEDICINE CO2NOVARTIS AG2OHIO STATE INNOVATION FOUNDATION1
Top patents by PatentIndex Score
10 records- 0184US11274142B2Fusion protein containing TGF-β receptor and medicinal uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Mar 15, 2022·3 cites·16 claims
- 0276US11943115B2Locally debugging remote deployment of microservicesIBM·Filed 2022·Granted Mar 26, 2024·1 cites·19 claims
- 0376US10047155B2Antibodies targeting bone morphogenetic protein 9 (BMP9) and methods thereforNOVARTIS AG·Filed 2016·Granted Aug 14, 2018·3 cites·34 claims
- 0466US11163959B2Cognitive predictive assistance for word meaningsIBM·Filed 2018·Granted Nov 2, 2021·1 cites·20 claims
- 0562US2024185947A1Artificial ketoreductase variants and the design methodology thereofENZYMASTER NINGBO BIO ENG CO LTD·Filed 2022·Application pending·0 cites
- 0654US10457631B2Biodegradable amino-ester nanomaterials for nucleic acid deliveryOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Oct 29, 2019·0 cites·20 claims
- 0754US2022153853A1Bispecific proteinJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 0854US2025043323A1Biocatalysts and methods for the synthesis of pregabalin intermediatesENZYMASTER NINGBO BIO ENG CO LTD·Filed 2022·Application pending·0 cites
- 0953US2024010748A1Bispecific antibody for claudin 18a2 and cd3 and application of bispecific antibodySHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2021·Application pending·0 cites
- 1045US2019153084A1Antibodies targeting bone morphogenetic protein 9 (bmp9) and methods thereforNOVARTIS AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiao Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →